Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)

NCT04084080 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT04084080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Lead sponsor
University of Pittsburgh
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 26, 2020
Completion date
October 31, 2026
Enrollment
173 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease